MPLTMapLight Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of MapLight Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MPLT본 종목 | $513M#7 | 0.3x#1 | 1.5x#2 | — | — | -107.7%#12 | — | -46.3%#10 | — | — | — | — |
| STTK | $599M#1 | — | 2.8x#10 | 599.2x#11 | -82.5%#11 | 35.3%#3 | -5150.8%#11 | -23.1%#7 | — | — | 233.5%#2 | — |
| CTMX | $588M#2 | — | 1.9x#5 | 7.7x#7 | -44.8%#9 | -154.5%#13 | -29.3%#4 | -5.7%#4 | -7.8%#2 | — | 35.7%#6 | — |
| ANNX | — | — | — | — | — | -49.6%#10 | — | -111.1%#12 | — | — | — | — |
| ARVN | $541M#3 | 31.8x#4 | 1.0x#1 | 2.1x#2 | -0.3%#5 | 59.3%#2 | -45.1%#5 | -14.4%#6 | -25.3%#3 | — | — | — |
| ASMB | $531M#4 | 21.0x#3 | 1.7x#4 | 7.3x#6 | 153.5%#2 | 84.8%#1 | -16.8%#3 | -2.0%#3 | -4.4%#1 | — | 22.9%#7 | — |
| OVID | $529M#5 | — | 2.5x#8 | 73.0x#10 | 1181.3%#1 | 34.1%#4 | -585.2%#9 | -8.3%#5 | — | — | — | — |
| EOLS | $522M#6 | — | — | 1.8x#1 | 11.6%#4 | -2.4%#8 | -11.0%#2 | — | -40.5%#4 | 4#1 | 19.3%#8 | — |
| CAPR | $498M#8 | — | 2.0x#6 | — | -100.0%#13 | -159.6%#14 | — | -42.7%#9 | — | — | 41.9%#5 | — |
| IRD | $483M#9 | — | — | 34.0x#8 | 29.1%#3 | 13.8%#6 | -271.9%#8 | — | — | — | 326.8%#1 | — |
| INDP | $482M#10 | — | 42.4x#13 | — | — | -38.8%#9 | — | -183.3%#13 | — | — | 57.4%#4 | — |
| PBYI | $478M#11 | 18.2x#2 | 3.5x#11 | 2.1x#3 | -0.9%#6 | 2.8%#7 | 16.3%#1 | 22.5%#1 | — | — | 99.8%#3 | — |
| RLMD | $475M#12 | — | 2.3x#7 | 92548.4x#12 | -35.4%#8 | — | -1152275.3%#12 | 0.0%#2 | — | — | — | — |
| ARCT | $450M#13 | — | 2.6x#9 | 5.5x#5 | -46.1%#10 | 18.7%#5 | -93.0%#6 | -38.3%#8 | -136.2%#5 | — | — | — |
| PRTA | $429M#14 | — | 1.5x#3 | 44.3x#9 | -92.8%#12 | -99.6%#11 | -2216.4%#10 | -85.1%#11 | — | — | — | — |
| SPRY | $421M#15 | — | 33.7x#12 | 5.0x#4 | -5.5%#7 | -2241.8%#15 | -212.9%#7 | -1369.1%#14 | -177.6%#6 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice